Evaluating a harm reduction plan for homeless individuals in New York City
CE24-013 - Community-based evaluation of a novel, system-wide harm reduction strategic plan for people experiencing homelessness in New York City
This study is looking at a new way to help people who are homeless in New York City stay safe from overdoses by teaching them about harm reduction and providing them with treatment services, and it will see how well these efforts work in real life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10993880 on NIH RePORTER |
What this research studies
This research investigates a comprehensive harm reduction strategy aimed at reducing overdose risks among people experiencing homelessness in New York City. The approach includes providing universal harm reduction education to all shelter clients and offering targeted treatment services. By analyzing data from homeless services, Medicaid claims, and vital records, the study aims to assess the effectiveness of these interventions in a real-world setting. The research employs a mixed-methods design, combining quantitative and qualitative data to evaluate the impact of the program.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing homelessness who are at risk of drug overdose.
Not a fit: Patients who are not experiencing homelessness or are not at risk of drug overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce overdose deaths among homeless individuals in New York City.
How similar studies have performed: While harm reduction strategies have been implemented in various contexts, this specific approach tailored for a large homeless services system is novel and has not been extensively tested.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Allen, Bennett — New York University School of Medicine
- Study coordinator: Allen, Bennett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.